Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Ensysce Biosciences files Form 3 for President, Director James William Morrison

Ensysce Biosciences files Form 3 for President, Director James William Morrison

ReutersReuters2026/08/10 20:06
  • Ensysce Biosciences President, director James William Morrison reported indirect holdings of Series C Non-Voting Convertible Preferred Stock convertible into 154,821,000 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036856), on August 10, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!